Cat. No. | Product name | CAS No. |
DC8739 |
Talabostat mesylate
Talabostat mesilate(PT-100; Val-boroPro) is an orally active, specific inhibitor of dipeptidyl peptidases(IC50=1 nM for DPP4), including tumor-associated fibroblast activation protein. |
150080-09-4 |
DC8223 |
TP-0903
Featured
TP-0903 is a a high-affinity Axl inhibitor with IC50 of 27 nM. |
1341200-45-0 |
DC8884 |
Voxtalisib (XL765, SAR245409)
Featured
Voxtalisib (SAR245409, XL765) is a dual inhibitor of mTOR/PI3K, mostly for p110γ with IC50 of 9 nM; also inhibits DNA-PK and mTOR. |
934493-76-2 |
DC1077 |
ZSTK474
Featured
ZSTK474 is a potent pan-class I PI3K inhibitor with IC50 of 37 nM. |
475110-96-4 |
DC10764 |
Theliatinib (HMPL-309)
Featured
Theliatinib (HMPL-309) is a novel small molecule, EGFR tyrosine kinase inhibitor with potential antineoplastic and anti-angiogenesis activities. |
1353644-70-8 |
DC10034 |
GLPG0187
Featured
GLPG0187 is a small molecule integrin receptor antagonist (IRA) with potential antineoplastic activity. |
1320346-97-1 |
DC11089 |
TAS-120 (Futibatinib)
Featured
TAS-120 is a highly potent and selective irreversible FGFR inhibitor, effective in tumors harboring various FGFR gene abnormalities. |
1448169-71-8 |
DC7622 |
BIBX1382
Featured
BIBX 1382 is a potent, selective inhibitor of EGFR tyrosine kinase (IC50 = 3 nM); displays > 1000-fold lower potency against ErbB2 (IC50 = 3.4 μM) and a range of other related tyrosine kinases (IC50 > 10 μM). |
196612-93-8 |
DC7488 |
RO4987655
Featured
RO4987655(CH-4987655) is an orally active small molecule, targeting mitogen-activated protein kinase kinase 1 (MAP2K1/MEK1 IC50=5.2 nM), with potential antineoplastic activity. |
874101-00-5 |